Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Low-dose aspirin affects the small bowel mucosa: results of a pilot study with a multidimensional assessment.

Smecuol E, Pinto Sanchez MI, Suarez A, Argonz JE, Sugai E, Vazquez H, Litwin N, Piazuelo E, Meddings JB, Bai JC, Lanas A.

Clin Gastroenterol Hepatol. 2009 May;7(5):524-9. doi: 10.1016/j.cgh.2008.12.019. Epub 2008 Dec 27.

PMID:
19249402
2.

Combination of low-dose aspirin and thienopyridine exacerbates small bowel injury.

Shiotani A, Honda K, Murao T, Ishii M, Fujita M, Matsumoto H, Tarumi K, Kamada T, Sakakibara T, Haruma K.

Scand J Gastroenterol. 2011 Mar;46(3):281-6. doi: 10.3109/00365521.2010.533381. Epub 2010 Dec 7.

PMID:
21133822
3.

Differences in the severity of small bowel mucosal injury based on the type of aspirin as evaluated by capsule endoscopy.

Endo H, Sakai E, Higurashi T, Yamada E, Ohkubo H, Iida H, Koide T, Yoneda M, Abe Y, Inamori M, Hosono K, Takahashi H, Kubota K, Nakajima A.

Dig Liver Dis. 2012 Oct;44(10):833-8. doi: 10.1016/j.dld.2012.05.016. Epub 2012 Jun 28.

PMID:
22749649
4.

Incidence of small bowel injury induced by low-dose aspirin: a crossover study using capsule endoscopy in healthy volunteers.

Endo H, Hosono K, Inamori M, Kato S, Nozaki Y, Yoneda K, Akiyama T, Fujita K, Takahashi H, Yoneda M, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Matsuhashi N, Nakajima A.

Digestion. 2009;79(1):44-51. doi: 10.1159/000204465. Epub 2009 Feb 26.

PMID:
19246922
5.

Fecal calprotectin and S100A12 have low utility in prediction of small bowel Crohn's disease detected by wireless capsule endoscopy.

Sipponen T, Haapamäki J, Savilahti E, Alfthan H, Hämäläinen E, Rautiainen H, Koskenpato J, Nuutinen H, Färkkilä M.

Scand J Gastroenterol. 2012 Jul;47(7):778-84. doi: 10.3109/00365521.2012.677953. Epub 2012 Apr 23.

PMID:
22519419
6.

Proximal predominance of small bowel injury associated with uncoated low-dose aspirin therapy: a video capsule study in chronic users.

Ehrhard F, Nazeyrollas P, Brixi H, Heurgue-Berlot A, Thiéfin G.

Eur J Gastroenterol Hepatol. 2013 Nov;25(11):1265-72. doi: 10.1097/MEG.0b013e3283640fad.

PMID:
23873021
7.

A quantitative analysis of NSAID-induced small bowel pathology by capsule enteroscopy.

Maiden L, Thjodleifsson B, Theodors A, Gonzalez J, Bjarnason I.

Gastroenterology. 2005 May;128(5):1172-8.

PMID:
15887101
9.

Fecal calprotectin: a selection tool for small bowel capsule endoscopy in suspected IBD with prior negative bi-directional endoscopy.

Koulaouzidis A, Douglas S, Rogers MA, Arnott ID, Plevris JN.

Scand J Gastroenterol. 2011 May;46(5):561-6. doi: 10.3109/00365521.2011.551835. Epub 2011 Jan 27.

PMID:
21269246
10.

Enteric coating of aspirin significantly decreases gastroduodenal mucosal lesions.

Dammann HG, Burkhardt F, Wolf N.

Aliment Pharmacol Ther. 1999 Aug;13(8):1109-14.

11.

Small bowel injury by low-dose enteric-coated aspirin and treatment with misoprostol: a pilot study.

Watanabe T, Sugimori S, Kameda N, Machida H, Okazaki H, Tanigawa T, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Higuchi K, Arakawa T.

Clin Gastroenterol Hepatol. 2008 Nov;6(11):1279-82. doi: 10.1016/j.cgh.2008.06.021.

PMID:
18995219
12.

Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease.

D'Haens G, Ferrante M, Vermeire S, Baert F, Noman M, Moortgat L, Geens P, Iwens D, Aerden I, Van Assche G, Van Olmen G, Rutgeerts P.

Inflamm Bowel Dis. 2012 Dec;18(12):2218-24. doi: 10.1002/ibd.22917. Epub 2012 Feb 16.

PMID:
22344983
13.

Characteristics of small bowel injury in symptomatic chronic low-dose aspirin users: the experience of two medical centers in capsule endoscopy.

Endo H, Hosono K, Inamori M, Nozaki Y, Yoneda K, Fujita K, Takahashi H, Yoneda M, Abe Y, Kirikoshi H, Kobayashi N, Kubota K, Saito S, Ohya T, Hisatomi K, Teratani T, Matsuhashi N, Nakajima A.

J Gastroenterol. 2009;44(6):544-9. doi: 10.1007/s00535-009-0040-z. Epub 2009 Apr 17.

PMID:
19373431
14.

Prophylactic aspirin therapy does not increase faecal calprotectin concentrations.

Montalto M, Curigliano V, Santoro L, Lombardi M, Covino M, Cammarota G, Dalvai S, D'Onofrio F, Gasbarrini A, Gasbarrini G.

Eur J Gastroenterol Hepatol. 2006 Sep;18(9):965-7.

PMID:
16894309
15.

Low-dose aspirin-induced gastroduodenal mucosal injury in Japanese patients with arteriosclerotic disease.

Tamura I, Fujita T, Tsumura H, Morita Y, Yoshida M, Toyonaga T, Hirano S, Inokuchi H, Kutsumi H, Azuma T.

Intern Med. 2010;49(23):2537-45. Epub 2010 Dec 1.

16.

Video capsule endoscopy to prospectively assess small bowel injury with celecoxib, naproxen plus omeprazole, and placebo.

Goldstein JL, Eisen GM, Lewis B, Gralnek IM, Zlotnick S, Fort JG; Investigators.

Clin Gastroenterol Hepatol. 2005 Feb;3(2):133-41.

PMID:
15704047
17.

Randomized, double-blind, pilot study of geranylgeranylacetone versus placebo in patients taking low-dose enteric-coated aspirin. Low-dose aspirin-induced small bowel damage.

Shiotani A, Haruma K, Nishi R, Fujita M, Kamada T, Honda K, Kusunoki H, Hata J, Graham DY.

Scand J Gastroenterol. 2010 Mar;45(3):292-8. doi: 10.3109/00365520903453182.

PMID:
19968611
18.

Aspirin-induced small bowel injuries and the preventive effect of rebamipide.

Mizukami K, Murakami K, Abe T, Inoue K, Uchida M, Okimoto T, Kodama M, Fujioka T.

World J Gastroenterol. 2011 Dec 14;17(46):5117-22. doi: 10.3748/wjg.v17.i46.5117.

19.

Omeprazole increased small intestinal mucosal injury in two of six disease-free cases evaluated by capsule endoscopy.

Fujimori S, Takahashi Y, Tatsuguchi A, Sakamoto C.

Dig Endosc. 2014 Sep;26(5):676-9.

PMID:
25383403
20.

The sugar absorption test in the evaluation of the gastrointestinal intolerance to bisphosphonates: studies with oral pamidronate.

Twiss IM, Burggraaf J, Schoemaker RC, van Elburg RM, den Hartigh J, Cohen AF, Vermeij P.

Clin Pharmacol Ther. 2001 Jun;69(6):431-7.

PMID:
11406740

Supplemental Content

Support Center